🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Camille Bigenwald

Institut Gustave Roussy

ORCID: 0000-0003-2714-2087
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance.

73 citations

Peng Liu, Misha Mao, Shuai Zhang, Camille Bigenwald, Charles‐Antoine Dutertre +18 more

Histiocytic disorders

Nature Reviews Disease Primers(2021)10.1038/s41572-021-00307-9
N/A
0.757DataRank · unranked
154 citations

Camille Bigenwald, Matthew Collin, Julien Haroche, Rebecca Marsh, Miriam Mérad +4 more

48 citations

Flurin Cathomas, Orsolya Török, Jessica Le Bérichel, Matthew D. Park, Camille Bigenwald +25 more

11 citations

Sebastien Viel, Benjamin Fournier, Sarah Benezech, Jérome Avouac, Marc Scherlinger +24 more